Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LONDON and SINGAPORE , Jan. 11, 2023 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that it achieved record international average daily volume (ADV) of 6.3 million contracts in 2022, up 15% from 2021. This record, reflecting all trading done outside the United States, was driven largely by growth in Equity Index and Foreign Exchange products, up 26% and 22% respectively.

CME Group Achieves Record International Average Daily Volume of 6.3 Million Contracts in 2022, Up 15% from 2021

Airbnb

Biohaven Pharmaceutical Hld

Cowen

Evo Payments

Garmin

Liberty Media Corp-Liberty SiriusXM

Mastercard

S&P Global

VMware

Paul Tudor Jones is one of the most respected names in the hedge fund industry.

These Are the Top 10 Holdings of Paul Tudor Jones

Adobe

Autodesk

Amazon

Bank of America

Comcast

Salesforce

Fortinet

Alphabet

Lam Research

Masco

Microchip Technology

MarketAxess Holdings

Monolithic Power Systems

ServiceNow

Palo Alto Networks

Polaris

Teradyne

U.S. Bancorp

Workday

Wells Fargo

West Pharmaceutical Services

Western Union

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.

U.S. Wide-Moat Stocks On Sale: The January 2023 Heat Map

CHICAGO and LONDON , Jan. 5, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and CF Benchmarks, the leading provider of cryptocurrency benchmark indices, today announced plans to launch three new Metaverse reference rates and real-time indices, which will be calculated and published daily by CF Benchmarks, beginning January 30. These reference rates and indices are not tradable futures products.

CME Group and CF Benchmarks to Launch Three New Metaverse Reference Rates and Real-Time Indices on January 30

-       Equity Index ADV grew 39% for the year and 26% in Q4 -       Interest Rate ADV up 18% annually, driven by record SOFR volume and OI -       Highest-ever Q4 ADV CHICAGO , Jan. 4, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its full-year, Q4 and December 2022 market statistics, showing it reached a record average daily volume (ADV) of 23.3 million contracts during the year, an increase of 19% over 2021. ADV increased 6% in the fourth quarter to 21.8 million contracts, and ADV increased 7% in December to 19.2 million contracts.

CME Group Reports Record Average Daily Volume of 23.3 Million Contracts Traded in 2022, an Increase of 19%

Falling bond prices were good news for CME Group.

The Bond Bear Market May Be Over. What This Means for CME Group.

Apple

AbbVie

Abbott Labs

Automatic Data Processing

Aflac

Ameriprise Financial

A. O. Smith

Broadcom

Best Buy

Blackrock Inc

Blackstone Group

Cardinal Health

Cincinnati Financial

CVS Health

Diamond Hill Investment Group

Duke Energy

Enterprise Products Partners

Fortune Brands Innovations Inc

Healthcare Services Group

Home Depot

Honeywell

Intercontinental Exchange

Intel

Johnson & Johnson

2022 was another fantastic year for dividend growth, with my income increasing by over 13%. I recount every sale made during the year and the replacement purchases.

My Dividend Growth Portfolio - Final 2022 Recap

Amgen

Air Products and Chemicals

Bristol-Myers

ConocoPhillips

Review of the current holdings and sectors in the portfolio, and how it has changed over the years. Income projections for 2023, and potential pitfalls.

2023 Dividend Growth Portfolio Review And Look Ahead

CME Group is my worst-performing dividend stock, as I'm down 17%. However, I'm even more bullish now as the company offers tremendous value at these prices.

CME Group: One Of The Best High-Yielders On The Market

CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.

Why Should You Stay Invested in CME Group (CME) Stock Now?

Weyerhaeuser

These dividend stocks give their investors an extra special payment each year.

2 Dividend Stocks That Treat Their Investors With Something Special Each Year

CHICAGO , Dec. 14, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Micro WTI options volume surpassed 100,000 contracts on December 13, 2022. "Traders are facing unprecedented volatility as markets react to recession risk, OPEC and U.S production shifts, changing demand from China, geopolitical events and other factors," said Peter Keavey, Global Head of Energy and Environmental Products at CME Group.

CME Group's Micro WTI Options Volume Surpasses 100,000 Contracts Traded

CHICAGO , Dec. 14, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME), the world's leading derivatives marketplace, today announced it will conduct its 2023 annual meeting of shareholders at 10:00 a.m. Central Time on Thursday, May 4, 2023.

CME Group Announces 2023 Annual Meeting Date

CHICAGO , Dec. 13, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it has been recognized by Foundry's Computerworld as one of the Best Places to Work in IT – for the fifth consecutive year. The Best Places to Work in IT is an annual ranking of work environments for technology professionals by Computerworld.

CME Group Named to Computerworld's 2023 List of Best Places to Work in IT

Sensei Biotherapeutics

NEW YORK--( BUSINESS WIRE )--Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) (“Sensei” or the “Company”). The investigations concern whether certain of the Sensei's officers and directors breached their fiduciary duties to shareholders, by, among other things: (i) engaging in self-dealing; (ii) affirmatively approving transactions that harmed the Company; and (iii) failing to provide sufficient oversight of the Company's business practices.

Newman Ferrara LLP Announces Corporate Governance Investigations of Sensei Biotherapeutics, Inc. (SNSE)

Universidad Anahuac takes Top Honors First place team based in Latin America for third consecutive year CHICAGO , Dec. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the winners of its 19th annual University Trading Challenge, led by Universidad Anahuac in Mexico, the third consecutive Latin American team to earn top honors in the global competition. 19th Annual CME Group University Trading Challenge Winners Team Position University Name Country First Place Universidad Anahuac Mexico Second Place University of Bridgeport U.S. Third Place The University of Texas at Dallas U.S. Fourth Place Tecnologico de Monterrey Mexico Fifth Place University of Bogota Jorge Tadeo Lozano Colombia This year's four-week competition included nearly 500 teams, comprised of 1,975 undergraduate and graduate students from 208 universities around the world.

CME Group Names Winning Teams of 2022 University Trading Challenge

Highest-ever November ADV Record SOFR options volume and OI CHICAGO , Dec. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its November 2022 market statistics, showing average daily volume (ADV) increased 1% to 23.5 million contracts during the month, representing the company's highest November volume on record. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports November 2022 Monthly Market Statistics

Fortune Brands Home & Security

Estimated income for 2022 is up to a record $15,545, while the portfolio continues to crush the S&P 500. Buying was light as the market is up big from the October lows. I am skeptical of the market and expect better prices in the future.

My Dividend Growth Portfolio November Update - Healthcare Services Group Gets The Boot

News for CME Group Stock (CME)